메뉴 건너뛰기




Volumn 18, Issue 6, 2009, Pages 527-529

Recontacting patients who have tested negative for BRCA1 and BRCA2 mutations: How, who and why?

Author keywords

BRCA1; BRCA2; Hereditary breast ovarian cancer syndrome; Risk notification

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

EID: 70549083816     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-009-9254-8     Document Type: Note
Times cited : (13)

References (1)
  • 1
    • 0033452167 scopus 로고    scopus 로고
    • Genetic susceptibility for specific cancers. Medical liability of the clinician
    • 10.1002/(SICI)1097-0142(19991201)86:11+<2564::AID-CNCR13>3.0.CO;2-P 1:STN:280:DC%2BD3c%2FpsFKntA%3D%3D 10630182
    • MJ Severin 1999 Genetic susceptibility for specific cancers. Medical liability of the clinician Cancer 86 2564 10.1002/(SICI)1097-0142(19991201)86: 11+<2564::AID-CNCR13>3.0.CO;2-P 1:STN:280:DC%2BD3c%2FpsFKntA%3D%3D 10630182
    • (1999) Cancer , vol.86 , pp. 2564
    • Severin, M.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.